Live Breaking News & Updates on Translational Genomics Research|Page 8

Stay updated with breaking news from Translational genomics research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

(ARKG), (ARKK) - 2 Genomic Stocks That Ark Funds Highlighted On Investor Day


Share:
Ark Funds hosted an investor webinar Tuesday, sharing ideas on several industries and portfolio components, including a discussion on some names in the genomics space.
Ark Funds On Genomics: Ark Funds is well-known for its bullish thesis on the genomics market. The company has the
Ark Genomic Revolution ETF (BATS: ARKG), an ETF devoted to the growth of the segment.
Exact Sciences (NASDAQ: EXAS) was highlighted by Ark Funds analyst Simon Barnett.
The company has made a series of acquisitions that could help the company’s position in the market, he said. 
“Incorporating it all together, Exact can broaden out their portfolio [and] determine market share.”   ....

Cathie Wood , Simon Barnett , Detection Corp , Highcape Acquisition Corp , Translational Genomics Research Institute , Mark Funds , Funds On Genomics , Ark Genomic Revolution , Thrive Earlier Detection , Base Genomics , Exact Sciences , Translational Genomics Research , Disruptive Innovation According To Cathie Wood , Ark Innovation , Highcape Capital Acquisition , கேத்தி மரம் , சிமோன் பார்னெட் , கண்டறிதல் கார்ப் , மொழிபெயர்ப்பு மரபியல் ஆராய்ச்சி நிறுவனம் , பேழை நிதி , நிதி ஆன் மரபியல் , செழித்து வளருங்கள் முந்தைய கண்டறிதல் , அடித்தளம் மரபியல் , சரியான அறிவியல் , மொழிபெயர்ப்பு மரபியல் ஆராய்ச்சி , சீர்குலைக்கும் கண்டுபிடிப்பு இசைய க்கு கேத்தி மரம் ,

UK variant of coronavirus confirmed to be in Arizona, health officials confirm


UK variant of coronavirus confirmed to be in Arizona, health officials confirm
Its scientific name is B.1.1.7., but it is also known as the UK variant of the COVID-19 virus.
By:
abc15.com staff, Scripps National
Posted at 11:24 AM, Jan 29, 2021
and last updated 2021-01-30 19:17:10-05
PHOENIX — A variant of coronavirus first spotted in the United Kingdom has made its way to Arizona, health officials confirmed late Friday.
Sources initially alerted ABC15 Friday morning that the variant, which has been shown to spread more easily from person to person, had been detected in our state and that officials were in contact with the Centers for Disease Control and Prevention about its arrival. ....

United States , United Kingdom , David Engelthaler , Joseph Petrosino , Centers For Disease , Translational Genomics Research Institute , Baylor College Of Medicine , Utah Public Health Laboratory , Disease Control , Translational Genomics Research , Baylor College , Arizona Coronavirus News , Arizona News , Coronavirus Data Arizona , Coronavirus In Arizona , Covid Uk Variant Arizona , Covid Uk Variant In Arizona , Covid Variants , Phoenix News , Uk Coronavirus Variant , Uk Variant Covid In Arizona , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , மையங்கள் க்கு நோய் , மொழிபெயர்ப்பு மரபியல் ஆராய்ச்சி நிறுவனம் , பேலர் கல்லூரி ஆஃப் மருந்து ,

Study offers a differentiated patient-specific solution in minimal residual disease testing


Study offers a differentiated patient-specific solution in minimal residual disease testing
Exact Sciences Corp. (Nasdaq: EXAS) today announced that it has acquired a worldwide exclusive license to the proprietary TARDIS technology from the Translational Genomics Research Institute (TGen), an affiliate of City of Hope. This compelling and technically distinct approach will help expand Exact Sciences leadership in precision oncology and offers a differentiated patient-specific solution in minimal residual disease testing.
Analysis of DNA shed into a patient s blood stream can provide a noninvasive means of detecting the presence of a tumor. Patients who have undergone initial treatment may only have small amounts of tumor DNA in their blood, which can be difficult to detect with conventional technology. TARDIS was developed to be highly sensitive and customizable for each patient, including those with only a trace amount of tumor remaining following surgery or other locali ....

Jeffreym Trent , Robert Stone , Kevin Conroy , Emily Henderson , Sciences Corp , Translational Genomics Research Institute Tgen , National Cancer , Translational Genomics Research Institute , National Comprehensive Cancer Network , Exact Science , Science Translational Medicine , Exact Sciences , Research Director , Translational Genomics Research , National Cancer Institute Designated , Cancer Diagnostics , ராபர்ட் ஸ்டோந் , கெவின் கான்ராய் , எமிலி ஹென்டர்சன் , அறிவியல் கார்ப் , தேசிய புற்றுநோய் , மொழிபெயர்ப்பு மரபியல் ஆராய்ச்சி நிறுவனம் , தேசிய விரிவான புற்றுநோய் வலைப்பின்னல் , சரியான அறிவியல் , அறிவியல் மொழிபெயர்ப்பு மருந்து , ஆராய்ச்சி இயக்குனர் ,